{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T03:17:12Z","timestamp":1692328632627},"reference-count":113,"publisher":"Oxford University Press (OUP)","issue":"suppl_D","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1093\/eurheartj\/sux010","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T09:35:34Z","timestamp":1494927334000},"page":"D151-D162","source":"Crossref","is-referenced-by-count":1,"title":["Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures"],"prefix":"10.1093","volume":"19","author":[{"given":"Roberto","family":"Caporale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele Massimo","family":"Gulizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Borzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marino","family":"Scherillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Ledda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piersilvio","family":"Gerometta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Casolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Formigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Di Bartolomeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"key\n\t\t\t\t20170725102406_sux010-B1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B2","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"CLARITY-TIMI 28 Investigators","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170725102406_sux010-B5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00392-011-0393-1","article-title":"Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial","volume":"101","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B6","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.ijcard.2013.07.012","article-title":"Comparison of pre-hospital 600\u2009mg or 900\u2009mg vs. peri-interventional 300\u2009mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial","volume":"168","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B7","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2012.50788","article-title":"Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"308","author":"for the ACTION Study Group","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170725102406_sux010-B8","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"PLATO Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"TRITON-TIMI 38 Investigators","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B11","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis","volume":"122","author":"PLATO Study Group","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"ATLANTIC Investigators","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B13","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehp118","article-title":"Risk profile and benefits from Gp IIb-IIIa inhi- bitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials","volume":"30","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(09)61484-7","article-title":"Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial","volume":"374","author":"HORIZONS-AMI Trial Investigators","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B15","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.108.818617","article-title":"Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial","volume":"119","author":"Bavarian Reperfusion Alternatives Evaluation-3 (BRAVE-3) Study Investigators","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B16","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMoa0706816","article-title":"Facilitated PCI in patients with ST-elevation myocardial infarction","volume":"358","author":"FINESSE Investigators","year":"2008","journal-title":"N Eng J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jcin.2009.06.018","article-title":"Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals","volume":"2","author":"FINESSE Investigators","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20170725102406_sux010-B18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(11)60876-3","article-title":"Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial","volume":"378","author":"ATOLL Investigators","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B19","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"HORIZONS-AMI Trial Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B20","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","author":"HORIZONS-AMI Trial Investigators","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B21","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"HEAT-PPCI trial investigators","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1507854","article-title":"Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes","volume":"373","author":"MATRIX Investigators","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B23","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1160\/TH14-08-0681","article-title":"The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview","volume":"112","year":"2014","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170725102406_sux010-B24","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology working group on thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta-blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"key\n\t\t\t\t20170725102406_sux010-B26","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B27","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B28","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2011.01.006","article-title":"Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: results from the American College of Cardiology\u2019s NCDRw","volume":"161","year":"2011","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B29","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0002-9149(91)90944-G","article-title":"Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies","volume":"67","year":"1991","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B30","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2005.05.086","article-title":"The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes","volume":"46","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcin.2009.11.021","article-title":"Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial","volume":"3","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20170725102406_sux010-B32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clinthera.2013.01.009","article-title":"Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study","volume":"35","year":"2013","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170725102406_sux010-B33","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1002\/clc.22169","article-title":"Effect of statin pretreatment on myocardial perfusion in patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis","volume":"36","year":"2013","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4070\/kcj.2014.44.2.76","article-title":"Effect of high dose rosuvastatin loading before primary percutaneous coronary intervention on infarct size in patients with ST-segment elevation myocardial infarction","volume":"44","year":"2014","journal-title":"Korean Circ J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B35","first-page":"135","article-title":"Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction","volume":"12","year":"2015","journal-title":"J Geriatr Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B36","author":"Agenzia Italiana del Farmaco"},{"key":"key\n\t\t\t\t20170725102406_sux010-B37","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"ESC Committee for Practice Guidelines","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B38","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/eurheartj\/ehr373","article-title":"Antiplatelet agents for the treatment and prevention of atherothrombosis","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","author":"The RISC Group","year":"1990","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B40","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration cooperative study","volume":"309","year":"1983","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B41","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","article-title":"Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial","volume":"313","year":"1985","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170725102406_sux010-B44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B45","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","article-title":"Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes","volume":"369","author":"ACCOAST Investigators","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B46","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehu160","article-title":"Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B47","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"CHAMPION PLATFORM Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B48","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B49","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"CHAMPION PHOENIX Investigators","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B50","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","article-title":"Effect of cangrelor on peri-procedural out- comes in percutaneous coronary interventions: a pooled analysis of patient-level data","volume":"382","author":"CHAMPION Investigators","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102406_sux010-B51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: the ACUITY timing trial","volume":"297","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170725102406_sux010-B52","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2010.08.063","article-title":"Meta-analysis of randomized trials of glycoprotein IIb\/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy","volume":"107","year":"2011","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B54","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction. The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA guidelines) Bleeding Score","volume":"119","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/2048872614560505","article-title":"Contemporary antithrombotic strategies in patients with acute coronary syndromes admitted to cardiac care units in Italy: the EYESHOT study","volume":"4","author":"EYESHOT Investigators","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t20170725102406_sux010-B56","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4244\/EIJV6I8A171","article-title":"Treatment patterns in acute\u00a0coronary syndrome patients in the United Kingdom undergoing PCI","volume":"6","author":"APTOR Trial Investigators","year":"2011","journal-title":"EuroIntervention"},{"key":"key\n\t\t\t\t20170725102406_sux010-B57","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jcin.2012.05.008","article-title":"Use of invasive strategy in non-ST-segment elevation myocardial\u00a0infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome)","volume":"5","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20170725102406_sux010-B58","first-page":"211","article-title":"Delay to angiography and outcomes following presentation with high-risk, non-ST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events","volume":"95","author":"GRACE Investigators","year":"2009","journal-title":"Heart"},{"key":"key\n\t\t\t\t20170725102406_sux010-B59","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B60","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jacc.2009.03.062","article-title":"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb\/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial","volume":"54","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B61","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/eurheartj\/ehm224","article-title":"Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis","volume":"28","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B62","doi-asserted-by":"crossref","first-page":"e553.","DOI":"10.1136\/bmj.e553","article-title":"Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis","volume":"344","year":"2012","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170725102406_sux010-B63","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170725102406_sux010-B64","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B65","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.1988.03410140100032","article-title":"Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction","volume":"260","year":"1988","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170725102406_sux010-B66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ccd.25302","article-title":"High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials","volume":"85","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"key\n\t\t\t\t20170725102406_sux010-B67","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2009.05.028","article-title":"Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial","volume":"54","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B68","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization","volume":"35","author":"The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B69","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehn169","article-title":"Clopidogrel pre-treatment in stable angina: for all patients > 6\u2009h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial prague-8","volume":"29","author":"Investigators P-T","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B70","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa031859","article-title":"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel","volume":"350","author":"Investigators I-RS","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B71","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1093\/eurheartj\/ehq330","article-title":"ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention","volume":"31","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B72","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJMoa052711","article-title":"Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention","volume":"355","author":"STEEPLE Investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B73","first-page":"582","article-title":"Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 3 Trial Investigators. Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris:1-year results of the ISAR-REACT 3 trial","volume":"3","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/CIRCOUTCOMES.115.002430","article-title":"A call to reduce the use of bridging anticoagulation","volume":"9","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key\n\t\t\t\t20170725102406_sux010-B75","doi-asserted-by":"crossref","first-page":"e34450.","DOI":"10.1371\/journal.pone.0034450","article-title":"Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170725102406_sux010-B76","doi-asserted-by":"crossref","first-page":"e113352.","DOI":"10.1371\/journal.pone.0113352","article-title":"High-dose statin pretreatment decreases peri-procedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170725102406_sux010-B77","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1016\/j.ijcard.2013.06.017","article-title":"Comparison of high reloading rosuvastatin and atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial peri-procedural necrosis. The ROMA II trial","volume":"168","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B78","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.73.2.227","article-title":"Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease","volume":"73","year":"1986","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B79","first-page":"I286","article-title":"Pre- operative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting","volume":"112(Suppl I)","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B80","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00134-004-2388-0","article-title":"Coagulation disorders of cardiopulmonary bypass: A review","volume":"30","year":"2004","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B81","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.athoracsur.2008.07.114","article-title":"Surgical reexploration after cardiac operations: why a worse outcome?","volume":"86","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20170725102406_sux010-B82","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.athoracsur.2012.04.005","article-title":"Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence","volume":"94","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20170725102406_sux010-B83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ejcts\/ezr242","article-title":"Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients","volume":"42","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"key\n\t\t\t\t20170725102406_sux010-B84","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.athoracsur.2011.03.105","article-title":"Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both?","volume":"91","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20170725102406_sux010-B85","first-page":"528","article-title":"Stent coronarico e chirurgia: la gestione perioperatoria della terapia antiaggregante nel paziente portatore di stent coronarico candidato a intervento chirurgico","volume":"13","author":"Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)","year":"2012","journal-title":"G Ital Cardiol (Rome)"},{"key":"key\n\t\t\t\t20170725102406_sux010-B86","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Multicenter Study of Perioperative Ischemia Research Group","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B87","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehl334","article-title":"A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B88","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehn104","article-title":"The effect of pre-operative ASA on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies","volume":"29","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B89","first-page":"728","article-title":"ATACAS Investigators of the ANZCA Clinical Trials Network","volume":"374","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B91","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/eurheartj\/ehr422","article-title":"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticgrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B92","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jacc.2012.07.021","article-title":"Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102406_sux010-B93","first-page":"196","article-title":"Inefficacy of platelet transfusion to reverse ticagrelor","volume":"372372","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B94","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2015-01-622928","article-title":"Structural and functional characterization of a specific antidote for ticagrelor","volume":"125","year":"2015","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170725102406_sux010-B95","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.athoracsur.2012.07.086","article-title":"2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations","volume":"94","author":"Society of Thoracic Surgeons","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20170725102406_sux010-B96","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","article-title":"Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study","volume":"5","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"key\n\t\t\t\t20170725102406_sux010-B97","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of \u2019bridging\u2019 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","volume":"104","year":"2010","journal-title":"Br J Anaesth"},{"key":"key\n\t\t\t\t20170725102406_sux010-B98","first-page":"265","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"BRIDGE Investigators","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170725102406_sux010-B99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis","volume":"28","year":"2013","journal-title":"J Cardiac Surg"},{"key":"key\n\t\t\t\t20170725102406_sux010-B100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B101","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/01.CIR.0000063575.17904.4E","article-title":"American Heart Association\/American College of Cardiology Foundation Guide to Warfarin Therapy","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B102","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170725102406_sux010-B103","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/eurheartj\/eht557","article-title":"Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102406_sux010-B104","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.drudis.2014.05.013","article-title":"Reversal of target-specific oral anticoagulants","volume":"19","year":"2014","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t20170725102406_sux010-B105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for Dabigatran Reversal","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B106","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","article-title":"Andexanet Alfa for the reversal of factor Xa inhibitor activity","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1213\/01.ane.0000247805.00342.21","article-title":"Perioperative \u03b2-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis","volume":"104","year":"2007","journal-title":"Anesth Analg"},{"key":"key\n\t\t\t\t20170725102406_sux010-B108","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.athoracsur.2011.03.088","article-title":"Preoperative \u03b2-blocker usage: is it really worthy of being a quality indicator?","volume":"92","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20170725102406_sux010-B109","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jamainternmed.2014.2356","article-title":"Preoperative \u03b2-blocker use in coronary artery bypass grafting surgery national database analysis","volume":"174","year":"2014","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20170725102406_sux010-B110","first-page":"S1","article-title":"2013 ACC\/AHA Guideline on the treatmentof blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"129(Suppl 2)","author":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B111","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association","volume":"131","author":"American Heart Association Council on Cardiovascular Surgery and Anesthesia","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B112","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.108.799445","article-title":"Impact of statin use on outcomes after coronary artery bypass graft surgery","volume":"118","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102406_sux010-B113","first-page":"CD008493","article-title":"Preoperative statin therapy for patients undergoing cardiac surgery","volume":"8","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/19\/suppl_D\/D151\/19286214\/sux010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T15:24:39Z","timestamp":1503588279000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-lookup\/doi\/10.1093\/eurheartj\/sux010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":113,"journal-issue":{"issue":"suppl_D","published-online":{"date-parts":[[2017,5,2]]},"published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/sux010","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}